Risk of malignancy in resected pancreatic mucinous cystic neoplasms

Keane, M.; Shamali, A.; Nilsson, L.; Antila, A.; Bocos, J.; Van Zanten, M.; Gil, C.; Maisonneuve, P.; Vaalavuo, Y.; Hoskins, T.; Robinson, S.; Ceyhan, GÜRALP; Abu Hilal, M.; Pereira, S.; Laukkarinen, J.; Del Chiaro, M.

doi:10.1002/bjs.10787

Risk of malignancy in resected pancreatic mucinous cystic neoplasms

Atıf İçin Kopyala

Keane M. G. , Shamali A., Nilsson L. N. , Antila A., Bocos J. M. , Van Zanten M. M. , ...Daha Fazla

BRITISH JOURNAL OF SURGERY, cilt.105, sa.4, ss.439-446, 2018 (SCI İndekslerine Giren Dergi)

Cilt numarası: 105 Konu: 4
Basım Tarihi: 2018
Doi Numarası: 10.1002/bjs.10787
Dergi Adı: BRITISH JOURNAL OF SURGERY
Sayfa Sayıları: ss.439-446

Özet

Pancreatic mucinous cystic neoplasms (MCNs) are rare mucin-producing cystic tumours defined by the presence of ovarian-type stroma. MCNs have a malignant potential and thus surgery is frequently performed. The aim of this cohort study was to define better the criteria for surgical resection in patients with MCN.